Suppr超能文献

乳腺癌患者血清对单核细胞Fc受体的可逆性抑制作用

Reversible inhibition of mononuclear cell Fc receptors by sera from breast cancer patients.

作者信息

Cillari E, Lio D, Salerno A

出版信息

J Clin Lab Immunol. 1984 May;14(1):23-7.

PMID:6235370
Abstract

The number of circulating mononuclear cells (MNC) expressing Fc receptor for IgG (Fc gamma R) was evaluated in 65 breast cancer patients and 37 normal controls by EAG rosette technique. The percentage (mean +/- SD) of Fc gamma + cells in patients (15.5 +/- 7.8) was significantly decreased (p less than 0.001) when compared to controls (20.4 +/- 5.6). The MNC of patients with low basal rosette values recovered their rosetting capacity when incubated in vitro at 37 degrees C. This effect was not related to detectable immune complexes (ICs). Some of the sera of breast cancer patients were also able to reversibly inhibit the capacity to form rosettes by MNC from healthy subjects. Our data suggest that serum factor(s), different from detectable ICs, might be responsible for this inhibiting effect.

摘要

采用EAG玫瑰花结技术对65例乳腺癌患者和37例正常对照者循环中表达IgG Fc受体(FcγR)的单核细胞(MNC)数量进行了评估。与对照组(20.4±5.6)相比,患者中Fcγ + 细胞的百分比(均值±标准差)(15.5±7.8)显著降低(p<0.001)。基础玫瑰花结值低的患者的MNC在37℃体外孵育时恢复了其玫瑰花结形成能力。这种效应与可检测到的免疫复合物(ICs)无关。一些乳腺癌患者的血清也能够可逆地抑制健康受试者MNC形成玫瑰花结的能力。我们的数据表明,不同于可检测到的ICs的血清因子可能是这种抑制作用的原因。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验